The effect of lumboventricular lavage and simultaneous low-frequency head-motion therapy after severe subarachnoid hemorrhage: Results of a single center prospective Phase II trial

Journal of Neurosurgery

Volumn 108, Issue 6, 2008, Pages 1192-1199

  Hänggi, Daniel ^a   Liersch, Julia ^a   Turowski, Bernd ^a   Yong, Mei ^a   Steiger, Hans Jakob ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Aneurysm; Cerebral vasospasm; Cisternal lavage; Clot clearance rate; Head motion therapy; Subarachnoid hemorrhage

Indexed keywords

DEXAMETHASONE; NIMODIPINE; RINGER SOLUTION;

ADULT; AGED; ANEURYSM SURGERY; ARTICLE; BLOOD CLOT; BLOOD FLOW VELOCITY; BRAIN ANGIOGRAPHY; BRAIN ARTERY ANEURYSM; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VASOSPASM; BRAIN VENTRICLE; CATHETER; CLINICAL ARTICLE; CLINICAL TRIAL; COIL EMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DRUG DOSE REDUCTION; FOLLOW UP; GLASGOW COMA SCALE; HEAD MOVEMENT; HUMAN; INTRACRANIAL PRESSURE MONITORING; LAVAGE; MORBIDITY; NEUROLOGIC DISEASE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; SCORING SYSTEM; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

ADULT; AGED; CISTERNA MAGNA; FEMALE; HEAD MOVEMENTS; HUMANS; INFUSIONS, INTRALESIONAL; IRRIGATION; MALE; MIDDLE AGED; MOTION THERAPY, CONTINUOUS PASSIVE; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR; VASOSPASM, INTRACRANIAL;

EID: 44849083107     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/JNS/2008/108/6/1192     Document Type: Article

References (59)

1. Aaslid R: Transcranial Doppler assessment of cerebral vasospasm. Eur J Ultrasound 16:3-10, 2002
2. Adams HP Jr, Kassell NF, Torner JC, Haley EC Jr: Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the Cooperative Aneurysm Study. Neurology 37:1586-1591, 1987
3. Amin-Hanjani S, Ogilvy CS, Barker FG II: Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery 54:326-335, 2004
4. Aoki N: "Head-shaking syndrome" neurological deterioration during continuous head-shaking as an adjunct to cisternal irrigation for clot removal in patients with acute subarachnoid haemorrhage. Acta Neurochir (Wien) 132:20-25, 1995
5. Boecher-Schwarz HG, Fries G, Mueller-Forell W, Kessel G, Perneczky A: Cerebral blood flow velocities after subarachnoid haemorrhage in relation to the amount of blood clots in the initial computed tomography. Acta Neurochir (Wien) 140:573-578, 1998
6. Brouwers PJ, Dippel DW, Vermeulen M, Lindsay KW, Hasan D, van Gijn J: Amount of blood on computed tomography as an independent predictor after aneurysm rupture. Stroke 24:809-814, 1993
7. Brouwers PJ, Wijdicks EF, Van Gijn J: Infarction after aneurysm rupture does not depend on distribution or clearance rate of blood. Stroke 23:374-379, 1992
8. Charpentier C, Audibert G, Guillemin F, Civit T, Ducrocq X, Bracard S, et al: Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke 30:1402-1408, 1999
9. Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D, et al: Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke 32:2012-2020, 2001
10. de Oliveira JG, Beck J, Ulrich C, Rathert J, Raabe A, Seifert V: Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurg Rev 30:22-31, 2007
11. Findlay JM: A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 37:1026-1027, 1995
12. Findlay JM, Deagle GM: Causes of morbidity and mortality following intracranial aneurysm rupture. Can J Neurol Sci 25:209-215, 1998
13. Findlay JM, Weir BK, Kassell NF, Disney LB, Grace MG: Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 75:181-188, 1991
14. Findlay JM, Weir BK, Steinke D, Tanabe T, Gordon P, Grace M: Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH. J Neurosurg 69:723-735, 1988
15. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1-9, 1980
16. Friedman JA, Goerss SJ, Meyer FB, Piepgras DG, Pichelmann MA, McIver JI, et al: Volumetric quantification of Fisher Grade 3 aneurysmal subarachnoid hemorrhage: a novel method to predict symptomatic vasospasm on admission computerized tomography scans. J Neurosurg 97:401-407, 2002
17. Gorski R, Zabek M, Jarmuzek P: Influence of intraoperative using of recombinant tissue plasminogen activator on the development of cerebral angiospasm after subarachnoid haemorrhage in patients with ruptured intracranial aneurysms. Neurol Neurochir Pol 34:41-47, 2000
18. Handa Y, Weir BK, Nosko M, Mosewich R, Tsuji T, Grace M: The effect of timing of clot removal on chronic vasospasm in a primate model. J Neurosurg 67:558-564, 1987
19. Hijdra A, van Gijn J, Nagelkerke NJ, Vermeulen M, van Crevel H: Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke 19:1250-1256, 1988
20. Hirashima Y, Kurimoto M, Takaba M, Endo S, Takaku A: The use of computed tomography in the prediction of delayed cerebral infarction following acute aneurysm surgery for subarachnoid haemorrhage. Acta Neurochir (Wien) 132:9-13, 1995
21. Hoh BL, Topcuoglu MA, Singhal AB, Pryor JC, Rabinov JD, Rordorf GA, et al: Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery 55:779-789, 2004
22. Inagawa T, Yamamoto M, Kamiya K: Effect of clot removal on cerebral vasospasm. J Neurosurg 72:224-230, 1990
23. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 73:18-36, 1990
24. Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results. J Neurosurg 73:37-47, 1990
25. Kasuya H, Shimizu T, Kagawa M: The effect of continuous drainage of cerebrospinal fluid in patients with subarachnoid hemorrhage: a retrospective analysis of 108 patients. Neurosurgery 28:56-59, 1991
26. Kasuya H, Shimizu T, Takakura K: Thrombin activity in CSF after SAH is correlated with the degree of SAH the persistence of subarachnoid clot and the development of vasospasm. Acta Neurochir (Wien) 140:579-584, 1998
27. Kawakami Y, Shimamura Y: Cisternal drainage after early operation of ruptured intracranial aneurysm. Neurosurgery 20:8-14, 1987
28. Kawamoto S, Tsutsumi K, Yoshikawa G, Shinozaki MH, Yako K, Nagata K, et al: Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 100:236-243, 2004
29. Kistler JP, Crowell RM, Davis KR, Heros R, Ojemann RG, Zervas T, et al: The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: a prospective study. Neurology 33:424-436, 1983
30. Klimo P Jr, Kestle JR, MacDonald JD, Schmidt RH: Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 100:215-224, 2004
31. Kodama N, Sasaki T, Kawakami M, Sato M, Asari J: Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients. Surg Neurol 53:110-118, 2000
32. Lindegaard KF: The role of transcranial Doppler in the management of patients with subarachnoid haemorrhage-a review. Acta Neurochir Suppl 72:59-71, 1999
33. Lindsay KW, Teasdale G, Knill-Jones RP, Murray L: Observer variability in grading patients with subarachnoid hemorrhage. J Neurosurg 56:628-633, 1982
34. Lindsay KW, Teasdale GM, Knill-Jones RP: Observer variability in assessing the clinical features of subarachnoid hemorrhage. J Neurosurg 58:57-62, 1983
35. Ljunggren B, Brandt L, Kagstrom E, Sundbarg G: Results of early operations for ruptured aneurysms. J Neurosurg 54:473-479, 1981
36. Macdonald RL, Rosengart A, Huo D, Karrison T: Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage. J Neurosurg 99:644-652, 2003
37. Majchrzak H, Lech A, Kopera M, Gajos L, Dragan T, Ladzinski P: [Application of alteplase in prevention of cerebral vasospasm and its sequelae in patients after aneurysmal subarachnoid hemorrhage from ruptured cerebral aneurysm.] Neurol Neurochir Pol 29:379-387, 1995 (Polish)
38. Mizoi K, Yoshimoto T, Fujiwara S, Sugawara T, Takahashi A, Koshu K: Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: preliminary report. Neurosurgery 28:807-813, 1991
39. Mizoi K, Yoshimoto T, Takahashi A, Fujiwara S, Koshu K, Sugawara T: Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg 78:430-437, 1993
40. Mizukami M, Kawase T, Usami T, Tazawa T: Prevention of vasospasm by early operation with removal of subarachnoid blood. Neurosurgery 10:301-307, 1982
41. Moriyama E, Matsumoto Y, Meguro T, Tazawa T: Combined cisternal drainage and intrathecal urokinase injection therapy for prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 35:732-736, 1995
42. Nilsson OG, Saveland H, Ramgren B, Cronqvist M, Brandt L: Impact of coil embolization on overall management and outcome of patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 57:216-224, 2005
43. Nosko M, Weir BK, Lunt A, Grace M, Allen P, Mielke B: Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model. J Neurosurg 66:416-422, 1987
44. Ohman J, Servo A, Heiskanen O: Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75:197-201, 1991
45. Rabinstein AA, Pichelmann MA, Friedman JA, Piepgras DG, Nichols DA, McIver JI, et al: Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion. J Neurosurg 98:319-325, 2003
46. Reilly C, Amidei C, Tolentino J, Jahromi BS, Macdonald RL: Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 101:255-261, 2004
47. Sakaki S, Ohta S, Kuwabara H, Shiraishi M: The role of ventricular and cisternal drainage in the early operation for ruptured intracranial aneurysms. Acta Neurochir (Wien) 88:87-94, 1987
48. Sasaki T, Ohta T, Kikuchi H, Takakura K, Usui M, Ohnishi H, et al: A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 35:597-605, 1994
49. Seifert V, Stolke D, Zimmermann M, Feldges A: Prevention of delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage by intrathecal bolus injection of tissue plasminogen activator (rTPA). A prospective study. Acta Neurochir (Wien) 128:137-143, 1994
50. Steinberg GK, Vanefsky MA, Marks MP, Adler JR Jr, Koenig GH: Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 34:809-814, 1994
51. Suzuki IS, Takahashi H: Effect of head-shaking method on clot removal in cisternal irrigation, in Sano K (ed): Cerebral Vasospasm. Tokyo: University of Tokyo Press, 1990, pp 314-316
52. Suzuki J, Komatsu S, Sato T, Sakurai Y: Correlation between CT findings and subsequent development of cerebral infarction due to vasospasm in subarachnoid haemorrhage. Acta Neurochir (Wien) 55:63-70, 1980
53. Taneda M: Effect of early operation for ruptured aneurysms on prevention of delayed ischemic symptoms. J Neurosurg 57:622-628, 1982
54. Teasdale G, Jennett B: Assessment of coma and impaired consciousness. A practical scale. Lancet 2:81-84, 1974
55. Teasdale GM, Drake CG, Hunt W, Kassel N, Sano K, Pertuiset B, et al: A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry 51:1457, 1988
56. Treggiari-Venzi MM, Suter PM, Romand JA: Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery 48:249-262, 2001
57. Usui M, Saito N, Hoya K, Todo T: Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Neurosurgery 34:235-245, 1994
58. van der Jagt M, Hasan D, Bijvoet HW, Pieterman H, Koudstaal PJ, Avezaat CJ: Interobserver variability of cisternal blood on CT after aneurysmal subarachnoid hemorrhage. Neurology 54:2156-2158, 2000
59. Zabramski JM, Spetzler RF, Lee KS, Papadopoulus SM, Bovill E, Zimmermann RS, et al: Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75:189-196, 1991